Feedback / Questions
BLB-101 - BayLink Biosciences
ASN-7350 - Asieris
https://www.prnewswire.com/news-releases/asieris-pharmaceuticals-releases-2024-annual-report-with-revenue-exceeding-rmb-200m-in-1st-year-of-commercialization-and-innovative-portfolio-accelerating-toward-launch-302432475.html
Apr 18, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next